172 related articles for article (PubMed ID: 19885316)
1. The antitumor effect and hepatotoxicity of a hexokinase II inhibitor 3-bromopyruvate: in vivo investigation of intraarterial administration in a rabbit VX2 hepatoma model.
Jae HJ; Chung JW; Park HS; Lee MJ; Lee KC; Kim HC; Yoon JH; Chung H; Park JH
Korean J Radiol; 2009; 10(6):596-603. PubMed ID: 19885316
[TBL] [Abstract][Full Text] [Related]
2. FDG-PET for evaluating the antitumor effect of intraarterial 3-bromopyruvate administration in a rabbit VX2 liver tumor model.
Park HS; Chung JW; Jae HJ; Kim YI; Son KR; Lee MJ; Park JH; Kang WJ; Yoon JH; Chung H; Lee K
Korean J Radiol; 2007; 8(3):216-24. PubMed ID: 17554189
[TBL] [Abstract][Full Text] [Related]
3. Hepatic intra-arterial injection of 3-bromopyruvate in rabbit VX2 tumor.
Shin SW; Han H; Choo SW; Yoo BC; Park CK; Do YS; Lee JH; Lee DH; Choi D; Choo IW; Kim SS; Lee JY
Acta Radiol; 2006 Dec; 47(10):1036-41. PubMed ID: 17135005
[TBL] [Abstract][Full Text] [Related]
4. Transcatheter arterial chemoembolization with paclitaxel-lipiodol solution in rabbit VX2 liver tumor.
Yoon CJ; Chung JW; Park JH; Yoon YH; Lee JW; Jeong SY; Chung H
Radiology; 2003 Oct; 229(1):126-31. PubMed ID: 12944599
[TBL] [Abstract][Full Text] [Related]
5. Assessment of tumoricidal efficacy and response to treatment with 18F-FDG PET/CT after intraarterial infusion with the antiglycolytic agent 3-bromopyruvate in the VX2 model of liver tumor.
Liapi E; Geschwind JF; Vali M; Khwaja AA; Prieto-Ventura V; Buijs M; Vossen JA; Ganapathy-Kanniappan S; Wahl RL
J Nucl Med; 2011 Feb; 52(2):225-30. PubMed ID: 21233194
[TBL] [Abstract][Full Text] [Related]
6. Intraarterial therapy with a new potent inhibitor of tumor metabolism (3-bromopyruvate): identification of therapeutic dose and method of injection in an animal model of liver cancer.
Vali M; Liapi E; Kowalski J; Hong K; Khwaja A; Torbenson MS; Georgiades C; Geschwind JF
J Vasc Interv Radiol; 2007 Jan; 18(1 Pt 1):95-101. PubMed ID: 17296709
[TBL] [Abstract][Full Text] [Related]
7. Transcatheter arterial embolization with 188Rhenium-HDD-labeled iodized oil in rabbit VX2 liver tumor.
Yoon CJ; Chung JW; Park JH; Kim YI; Lee KH; Jeong JM; Paeng JC
J Vasc Interv Radiol; 2004 Oct; 15(10):1121-8. PubMed ID: 15466799
[TBL] [Abstract][Full Text] [Related]
8. Targeting of VX2 rabbit liver tumor by selective delivery of 3-bromopyruvate: a biodistribution and survival study.
Vali M; Vossen JA; Buijs M; Engles JM; Liapi E; Ventura VP; Khwaja A; Acha-Ngwodo O; Ganapathy-Kanniappan S; Syed L; Wahl RL; Geschwind JF
J Pharmacol Exp Ther; 2008 Oct; 327(1):32-7. PubMed ID: 18591216
[TBL] [Abstract][Full Text] [Related]
9. Local toxicity of hepatic arterial infusion of hexokinase II inhibitor, 3-bromopyruvate: In vivo investigation in normal rabbit model.
Chang JM; Chung JW; Jae HJ; Eh H; Son KR; Lee KC; Park JH
Acad Radiol; 2007 Jan; 14(1):85-92. PubMed ID: 17178370
[TBL] [Abstract][Full Text] [Related]
10. Hepatic parenchymal changes after the intraarterial injection of lipiodol in tumor-bearing rabbits.
Akashi Y; Koreeda C; Mizuno T; Inoue K; Kawa SK; Tanaka Y
Invest Radiol; 1993 Feb; 28(2):128-32. PubMed ID: 8383100
[TBL] [Abstract][Full Text] [Related]
11. Antitumor effects of intraarterial infusion of tumor necrosis factor/lipiodol emulsion on hepatic tumor in rabbits.
Watanabe D; Ueo H; Inoue H; Matsuoka H; Honda M; Shinomiya Y; Takamatsu T; Akiyoshi T
Oncology; 1995; 52(1):76-81. PubMed ID: 7800348
[TBL] [Abstract][Full Text] [Related]
12. Development of a new orthotopic animal model of metastatic liver cancer in the rabbit VX2 model: effect on metastases after partial hepatectomy, intra-arterial treatment with 3-bromopyruvate and chemoembolization.
Vossen JA; Buijs M; Syed L; Kutiyanwala F; Kutiyanwala M; Geschwind JF; Vali M
Clin Exp Metastasis; 2008; 25(7):811-7. PubMed ID: 18649116
[TBL] [Abstract][Full Text] [Related]
13. Effect of transcatheter intraarterial therapies on the distribution of Doxorubicin in liver cancer in a rabbit model.
Liang B; Xiong F; Wu H; Wang Y; Dong X; Cheng S; Feng G; Zhou G; Xiong B; Liang H; Xia X; Zheng C
PLoS One; 2013; 8(10):e76388. PubMed ID: 24116106
[TBL] [Abstract][Full Text] [Related]
14. [Anti-tumor activity of zinostatin stimalamer (YM 881) examined by human hepatoma cells in vitro and VX2 liver tumor in vivo].
Tanaka S; Fujihara A; Yamamoto M; Asano M; Ida H; Ohmi Y; Kitazaki T; Kikuchi Y; Yoshida S; Okamiya H
Gan To Kagaku Ryoho; 1994 Feb; 21(2):219-26. PubMed ID: 8311492
[TBL] [Abstract][Full Text] [Related]
15. Antitumor activity of zinostatin stimalamer (YM881) in human hepatoma cell lines and VX2 liver tumor-bearing rabbits.
Tanaka S; Fujihara A; Yamamoto M; Ida H; Ohmi Y; Kitazaki T; Kikuchi Y; Yoshida S; Okamiya H; Numasaki Y; Konno T
Res Commun Mol Pathol Pharmacol; 1996 May; 92(2):155-63. PubMed ID: 8774069
[TBL] [Abstract][Full Text] [Related]
16. Augmentation of chemotherapeutic infusion effect by TSU-68, an oral targeted antiangiogenic agent, in a rabbit VX2 liver tumor model.
Kim HC; Chung JW; Choi SH; Im SA; Yamasaki Y; Jun S; Jae HJ; Park JH
Cardiovasc Intervent Radiol; 2012 Feb; 35(1):168-75. PubMed ID: 21184227
[TBL] [Abstract][Full Text] [Related]
17. [Effects of transcatheter arterial chemoembolization with pingyangmycin-lipiodol emulsion on VX2 liver tumors in rabbits].
Liu X; Luo XP; Cao WT; Deng H
Zhonghua Gan Zang Bing Za Zhi; 2012 Aug; 20(8):611-6. PubMed ID: 23207156
[TBL] [Abstract][Full Text] [Related]
18. Selective effect of doxorubicin suspended in lipiodol on VX2 carcinoma in rabbits.
Furuta T; Kanematsu T; Kakizoe S; Sugimachi K
J Surg Oncol; 1988 Dec; 39(4):229-34. PubMed ID: 2848154
[TBL] [Abstract][Full Text] [Related]
19. [Enhanced effect of hepatic arterial infused anticancer drugs on rabbit VX-2 carcinoma by means of combination with Lipiodol. Adriamycin versus Lipiodol adriamycin sandwich method and adriamycin suspended in a Lipiodol].
Hoshino M; Koyama Y; Sugano K; Kanno M; Satou N; Abe R
Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 2):2810-3. PubMed ID: 2551224
[TBL] [Abstract][Full Text] [Related]
20. [Hepatic parenchymal changes after intraarterial administration of lipiodol: an animal experiment].
Akashi Y; Koreeda C; Enomoto S; Nishimura T; Tateiwa J; Mizuno T; Inoue K; Koreeda T; Ha-Kawa SK
Nihon Igaku Hoshasen Gakkai Zasshi; 1991 Mar; 51(3):289-91. PubMed ID: 1646441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
